Hualan Biological Vaccine Inc. (SHE:301207)
China
· Delayed Price · Currency is CNY 19.25
-0.01 (-0.05%)
Apr 29, 2026, 3:00 PM CST
Hualan Biological Vaccine Revenue
Hualan Biological Vaccine had revenue of 26.78M CNY in the quarter ending March 31, 2026, with 10.27% growth. This brings the company's revenue in the last twelve months to 1.20B, up 7.79% year-over-year. In the year 2025, Hualan Biological Vaccine had annual revenue of 1.20B with 6.62% growth.
Revenue (ttm)
1.20B
Revenue Growth
+7.79%
P/S Ratio
9.51
Revenue / Employee
1.70M
Employees
708
Market Cap
11.46B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chongqing Genrix Biopharmaceutical | 230.72M |
| Pacific Shuanglin Bio-pharmacy | 2.38B |
| Chengdu Olymvax Biopharmaceuticals | 704.16M |
| Vcanbio Cell & Gene Engineering Corp., | 1.42B |
| Chengdu Easton Biopharmaceuticals | 1.35B |
| Jiangxi Fushine Pharmaceutical | 1.31B |
| HitGen | 525.57M |
| InventisBio | 37.29M |